Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Matson

Showing results (51-60 of 57) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 57 results.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 30, 2016
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotidesElizabeth J Ackermann, Shuling Guo, Merrill D Benson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2014
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesFrank Rigo, Seung J Chun, Daniel A Norris, et al.
Nucleic Acids Research|December 28, 2020
The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administrationPaymaan Jafar-Nejad, Berit Powers, Armand Soriano, et al.
Science Translational Medicine|March 4, 2011
Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
JCI Insight|October 18, 2019
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imagingCurt Mazur, Berit Powers, Kenneth Zasadny, et al.
Science Translational Medicine|May 14, 2025
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophyBeltran Borges, Stephen M Brown, Wan-Jin Chen, et al.
The Journal of Clinical Investigation|October 8, 2019
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatmentDaniel M Ramos, Constantin d'Ydewalle, Vijayalakshmi Gabbeta, et al.
Pageof 6

Showing results (51-60 of 57) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 57 results.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 30, 2016
Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotidesElizabeth J Ackermann, Shuling Guo, Merrill D Benson, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 3, 2014
Pharmacology of a central nervous system delivered 2'-O-methoxyethyl-modified survival of motor neuron splicing oligonucleotide in mice and nonhuman primatesFrank Rigo, Seung J Chun, Daniel A Norris, et al.
Nucleic Acids Research|December 28, 2020
The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administrationPaymaan Jafar-Nejad, Berit Powers, Armand Soriano, et al.
Science Translational Medicine|March 4, 2011
Antisense oligonucleotides delivered to the mouse CNS ameliorate symptoms of severe spinal muscular atrophyMarco A Passini, Jie Bu, Amy M Richards, et al.
JCI Insight|October 18, 2019
Brain pharmacology of intrathecal antisense oligonucleotides revealed through multimodal imagingCurt Mazur, Berit Powers, Kenneth Zasadny, et al.
Science Translational Medicine|May 14, 2025
Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophyBeltran Borges, Stephen M Brown, Wan-Jin Chen, et al.
The Journal of Clinical Investigation|October 8, 2019
Age-dependent SMN expression in disease-relevant tissue and implications for SMA treatmentDaniel M Ramos, Constantin d'Ydewalle, Vijayalakshmi Gabbeta, et al.
Pageof 6